291:HKEXChina Resources Beer (Holdings) Co. Ltd. Analysis
Data as of 2026-07-28 - not real-time
¥1,385.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Rock Field Co.,Ltd. is trading at ¥1,385, comfortably above its 20‑day (¥1,352.55), 50‑day (¥1,303.52) and 200‑day (¥1,369.08) moving averages, indicating short‑term strength, yet the price sits just below the identified resistance of ¥1,389. The RSI of 67 signals a market that is approaching overbought territory, while a bullish MACD (line above signal) offers a modest technical upside. Fundamentally, the stock appears stretched: a trailing P/E of 357 versus a forward P/E of 29, and a DCF‑derived fair value of ¥793 suggest the market is pricing in expectations far beyond current earnings. The company’s profit margins are razor‑thin (operating margin 0.6%, profit margin 0.19%) and ROE is only 0.34%, though it maintains a strong cash position and a low dividend payout ratio, supporting dividend sustainability.
Given the defensive consumer‑packaged‑foods sector, low beta (‑0.04) and stable volume, the stock benefits from limited systematic risk, but the combination of high valuation, modest growth prospects (0.9% revenue growth) and elevated debt‑to‑equity (3.35) raises concerns about upside potential. Investors should weigh the attractive 2.17% dividend against the overvalued price and thin profitability before deciding on positioning.
Given the defensive consumer‑packaged‑foods sector, low beta (‑0.04) and stable volume, the stock benefits from limited systematic risk, but the combination of high valuation, modest growth prospects (0.9% revenue growth) and elevated debt‑to‑equity (3.35) raises concerns about upside potential. Investors should weigh the attractive 2.17% dividend against the overvalued price and thin profitability before deciding on positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance at ¥1,389
- High trailing P/E relative to fair value
- Bullish MACD but limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Forward EPS growth expectations
- Defensive sector with low beta
- Sustainable dividend payout
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Persistently thin margins and low ROE
- Elevated debt‑to‑equity ratio
- Current price significantly above DCF fair value
Key Metrics & Analysis
Financial Health
Revenue Growth0.90%
Profit Margin0.19%
P/E Ratio357.0
ROE0.34%
ROA1.39%
Debt/Equity3.35
P/B Ratio1.3
Op. Cash Flow¥2.3B
Free Cash Flow¥638.5M
Technical Analysis
TrendNeutral
RSI67.2
Support¥1,309.00
Resistance¥1,389.00
MA 20¥1,352.55
MA 50¥1,303.52
MA 200¥1,369.08
MACDBullish
VolumeStable
Fear & Greed Index88.91
Valuation
Fair Value¥793.41
Target Price¥1,300.00
Upside/Downside-6.14%
GradeOvervalued
TypeBlend
Dividend Yield2.17%
Risk Assessment
Beta-0.04
Volatility15.34%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.